Skip to main content
Top
Published in: Urolithiasis 2/2012

01-04-2012 | Original Paper

Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats

Authors: Jun Mi, Jianmin Duan, Jun Zhang, Jianzhong Lu, Hanzhang Wang, Zhiping Wang

Published in: Urolithiasis | Issue 2/2012

Login to get access

Abstract

Chinese herbs Desmodium styracifolium (Ds) and Pyrrosiae petiolosa (Pp) have been widely used to treat urolithiasis with few side effects in traditional Chinese medicine (TCM). In vitro crystallization study has confirmed their prophylaxis of Calcium oxalate (CaO x ) stones formation. However, little is known on their possible mechanisms in vivo. In the present study, we proposed to systematically evaluate their antilithic effects and clarify the underlying mechanism of Ds and Pp using a rat nephrolithiasis model and administering the aqueous extracts. Adult male Wistar rats were fed with 5% ammonium oxalate (AmO x ) forage to induce nephrolithiasis. After 1 week, the rats were randomly divided into eight groups, and given low, medium, and high dose of each herb treatments (275, 550 and 1,100 mg/kg for Ds and 150, 300 and 600 mg/kg for Pp) by gavage for 3 weeks. In contrast to urolithic rats, urinary oxalate significantly reduced, and urinary calcium increased in medium and high dose Ds groups. Few depositions were observed in kidney with slight dilation of tubules and inflammatory infiltration. Osteopontin (OPN), nitric oxide (NO), and malondialdehyde (MDA) levels significantly decreased, but Superoxide dismutase (SOD) activities were enhanced in kidneys. In high dose Pp group, crystals were found in the dilation of tubules with slight inflammatory infiltration. Partial serum and urinary variables returned to the normal range. In conclusion, medium and high dose Ds has beneficial effect in preventing CaO x stone formation by rising urinary Citrate excretion, decreasing urinary calcium, diuresis, and antioxidative effects. Although high dose Pp has relatively weak prophylaxis, it indicates significant anti-inflammatory and antioxidant effects.
Literature
4.
6.
10.
go back to reference Kohri K, Nomura S, Kitamura Y et al (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268(20):15180–15184PubMed Kohri K, Nomura S, Kitamura Y et al (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268(20):15180–15184PubMed
12.
go back to reference Hess B (2003) Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi. Ther Umsch 60(2):79–87PubMedCrossRef Hess B (2003) Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi. Ther Umsch 60(2):79–87PubMedCrossRef
14.
go back to reference The State Pharmacopoeia Committee of China (2005) Pharmacopoeia Commission of the People’s Republic of China, vol vol.1. Chemical Industry Press, Beijing The State Pharmacopoeia Committee of China (2005) Pharmacopoeia Commission of the People’s Republic of China, vol vol.1. Chemical Industry Press, Beijing
20.
go back to reference Kumar S, Sigmon D, Miller T et al (1991) A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 146(5):1384–1389PubMed Kumar S, Sigmon D, Miller T et al (1991) A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 146(5):1384–1389PubMed
21.
go back to reference Hodgkinsona A, Williamsa Ann (1972) An improved colorimetric procedure for urine oxalate. Clinica Chimica Acta 36(1):127–132CrossRef Hodgkinsona A, Williamsa Ann (1972) An improved colorimetric procedure for urine oxalate. Clinica Chimica Acta 36(1):127–132CrossRef
22.
go back to reference Jacobs SL, Lee ND (1964) Determination of Citric Acid in Serum and Urine Using Br82. J Nucl Med 5:297–301PubMed Jacobs SL, Lee ND (1964) Determination of Citric Acid in Serum and Urine Using Br82. J Nucl Med 5:297–301PubMed
25.
go back to reference Doddametikurke RB, Chandra SB, Anthony JB et al (2007) The Role of Urinary Kidney Stone Inhibitors and Promoters in the Pathogenesis of Calcium Containing Renal Stones. EAU-EBU update series 5(3):126–136CrossRef Doddametikurke RB, Chandra SB, Anthony JB et al (2007) The Role of Urinary Kidney Stone Inhibitors and Promoters in the Pathogenesis of Calcium Containing Renal Stones. EAU-EBU update series 5(3):126–136CrossRef
26.
go back to reference Lemann JJ, Worcester EM, Gray RW (1991) Hypercalciuria and stones. Am J Kidney Dis 17(4):386–391PubMed Lemann JJ, Worcester EM, Gray RW (1991) Hypercalciuria and stones. Am J Kidney Dis 17(4):386–391PubMed
27.
go back to reference Borghi L, Meschi T, Amato F et al (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155(3):839–843PubMedCrossRef Borghi L, Meschi T, Amato F et al (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155(3):839–843PubMedCrossRef
28.
go back to reference Hirayama H, Wang Z, Nishi K et al (1993) Effect of Desmodium styracifolium-triterpenoid on calcium oxalate renal stones. Br J Urol 71(2):143–147PubMedCrossRef Hirayama H, Wang Z, Nishi K et al (1993) Effect of Desmodium styracifolium-triterpenoid on calcium oxalate renal stones. Br J Urol 71(2):143–147PubMedCrossRef
29.
go back to reference Daudon M, Jungers P, Lacour B (2004) Clinical value of crystalluria study. Ann Biol Clin 62(4):379–393 Daudon M, Jungers P, Lacour B (2004) Clinical value of crystalluria study. Ann Biol Clin 62(4):379–393
30.
go back to reference Hallson PC, Rose GA, Sulaiman S (1983) Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Urol Int 38(3):179–181PubMedCrossRef Hallson PC, Rose GA, Sulaiman S (1983) Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Urol Int 38(3):179–181PubMedCrossRef
31.
go back to reference Hallson PC, Rose GA (1976) Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment. Br J Urol 48(7):515–524PubMedCrossRef Hallson PC, Rose GA (1976) Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment. Br J Urol 48(7):515–524PubMedCrossRef
32.
go back to reference Ouyang JM, Deng SP (2003) Controlled and uncontrolled crystallization of calcium oxalate monohydrate in the presence of citric acid. Dalton Trans 63(14):2846–2851. doi:10.1039/b304319c CrossRef Ouyang JM, Deng SP (2003) Controlled and uncontrolled crystallization of calcium oxalate monohydrate in the presence of citric acid. Dalton Trans 63(14):2846–2851. doi:10.​1039/​b304319c CrossRef
35.
go back to reference Worcester EM, Beshensky AM (1995) Osteopontin inhibits nucleation of calcium oxalate crystals. Ann N Y Acad Sci 760:375–377PubMedCrossRef Worcester EM, Beshensky AM (1995) Osteopontin inhibits nucleation of calcium oxalate crystals. Ann N Y Acad Sci 760:375–377PubMedCrossRef
36.
go back to reference Hoyer JR (1994) Uropontin in urinary calcium stone formation. Miner Electrolyte Metab 20(6):385–392PubMed Hoyer JR (1994) Uropontin in urinary calcium stone formation. Miner Electrolyte Metab 20(6):385–392PubMed
37.
go back to reference Shiraga H, Min W, Van Dusen WJ et al (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89(1):426–430PubMedCrossRef Shiraga H, Min W, Van Dusen WJ et al (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89(1):426–430PubMedCrossRef
39.
go back to reference Lieske JC, Leonard R, Toback FG (1995) Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268(4 Pt 2):604–612 Lieske JC, Leonard R, Toback FG (1995) Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268(4 Pt 2):604–612
43.
go back to reference Volkan T, Eray Kemahli EO, Yasar Volkan A et al (2008) Protective Effect of a Potent Antioxidant, Pomegranate Juice, in the Kidney of Rats with Nephrolithiasis Induced by Ethylene Glycol. J Endourol 22(12):2723–2732. doi:10.1089/end.2008.0357 CrossRef Volkan T, Eray Kemahli EO, Yasar Volkan A et al (2008) Protective Effect of a Potent Antioxidant, Pomegranate Juice, in the Kidney of Rats with Nephrolithiasis Induced by Ethylene Glycol. J Endourol 22(12):2723–2732. doi:10.​1089/​end.​2008.​0357 CrossRef
45.
go back to reference Huang HS, Chen J, Chen CF et al (2006) Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors. Kidney Int 71(7):699–710. doi:10.1038/sj.ki.5002148 CrossRef Huang HS, Chen J, Chen CF et al (2006) Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors. Kidney Int 71(7):699–710. doi:10.​1038/​sj.​ki.​5002148 CrossRef
46.
go back to reference Ho-Shiang H, Ming-Chieh M, Chau-Fong C et al (2006) Changes in nitric oxide production in the rat kidney due to CaOx nephrolithiasis. Neurourol Urodyn 25(3):252–258. doi:10.1002/nau.20152 CrossRef Ho-Shiang H, Ming-Chieh M, Chau-Fong C et al (2006) Changes in nitric oxide production in the rat kidney due to CaOx nephrolithiasis. Neurourol Urodyn 25(3):252–258. doi:10.​1002/​nau.​20152 CrossRef
Metadata
Title
Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats
Authors
Jun Mi
Jianmin Duan
Jun Zhang
Jianzhong Lu
Hanzhang Wang
Zhiping Wang
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 2/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0401-y

Other articles of this Issue 2/2012

Urolithiasis 2/2012 Go to the issue